ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow ...

Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow ...

Medtech giant Abbott is buying New Brighton-based Cardiovascular Systems Inc. for $890 million, expanding its portfolio in treating artery disease. Cardiovascular Systems (CSI) specializes in ...

ABBOTT PARK, Ill., April 27, 2023 /PRNewswire/ -- Abbott (ABT) today announced it has completed the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative ...

“During Q4, we achieved strong sequential growth across all business segments with our U.S. peripheral and coronary atherectomy franchises growing 9% and 16% over prior quarter, respectively.

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...

Cardiovascular Systems Inc. (CSI) reported the submission by its partner Innova Vascular Inc. of U.S. FDA premarket notification for thrombectomy devices to treat peripheral vascular disease. Already ...

Cardiovascular Systems, Inc. (CSI) CSII, a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, ...

June 7, 2005 — The European Commission has approved an atherectomy device for the treatment of peripheral artery disease; Health Canada has approved a synthetic cartilage implant for the treatment of ...